Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · April 26, 2018

Efficacy and Impact on Quality of Life of Naldemedine in Patients With Opioid-Induced Constipation and Cancer

Annals of Oncology

 

Additional Info

Annals of Oncology
Randomized Phase 3 and Extension Studies: Efficacy and Impacts on Quality of Life of Naldemedine in Subjects With Opioid-Induced Constipation and Cancer
Ann. Oncol 2018 Apr 18;[EPub Ahead of Print], N Katakami, T Harada, T Murata, K Shinozaki, M Tsutsumi, T Yokota, M Arai, Y Tada, M Narabayashi, N Boku

Further Reading